A team of researchers published the results of a phase 1 clinical trial for the drug Givosiran, which targets the liver cells ultimately responsible for acute hepatic porphyrias.
Leung received $806,000 from the Gates Foundation to develop and test a smartphone app to help clinicians determine the cause of diarrhea in young children.
A partnership between U of U Health Plans and the state’s booming tech industry will be beneficial for both. Chad Westover, CEO, sees enormous potential in the agreement.
U of U Health aspires to be a place where patients want to come, where binding community partnerships are made, and where people want to work and train. Chief of...
We have a unique opportunity to help our state prepare for exceptional growth, while leading the nation in innovative practices, discoveries, and transfers of knowledge.
Researchers at University of Utah Health joined colleagues at the Ensign College of Public Health to evaluate the quality and safety of surgical care provided at the Volta River Authority...